focus -WSS

focus

author：leisure time 2025-10-01 21:37:43 - browse：4

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Physician executives need more than on

leisure time

WSS

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

AI can decode, harness the power of the humane immune system

Analysis of telehealth claims data suggest service duplication

Life sciences investors close nearly $6 billion in new funds

hotspot

focus

focus

Medical records are filled with copy

How neuroscience research could help beat back brain cancer

The high cost of giving birth even with insurance

Travis Kelce and the trap of celebrity vaccine endorsements

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Kidney transplant patients stopped immunosuppressants in trial

Guidelines to prevent youth baseball injuries need more muscle

Bill would stop addiction treatment from triggering child abuse inquiry

BioMarin wins approval for gene therapy to treat hemophilia A

Histogen: Failed biotech offers rare public look inside

entertainment

AI can decode, harness the power of the humane immune system

Explaining an after

Analysis of telehealth claims data suggest service duplication

Life sciences investors close nearly $6 billion in new funds

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

leisure time

leisure time

hotspot

leisure time